Abstract
The development of the health world will certainly have a positive impact for shareholders especially in pharmaceutical companies, this is reflected by the Government's support that provides ease and incentives in the form of tax deductions and import duties borne by the Government to attract investments. With these opportunities will certainly affect the price of stocks in pharmaceutical companies including the financial performance. Financial performance can be seen from several financial ratios, earning per share, debt to equity, and price earning ratio. Samples on this study were as many as 7 companies for 5 years so in 35 can sample. The results of this study simultaneously all variables in this study have an effect on the stock price. Both EPS and PER variables affect the stock price, while the DER variables negatively affect the share price.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
